EBITDA

Revolve Renewable Power bets big on Ontario's battery market with a new acquisition, but its high-interest, related-party financing raises critical questions.

A major shareholder is crying foul over the proposed Fairfax buyout of Andrew Peller, citing an unfair premium for voting shares and a lowball valuation.

Acacia Research's Q2 results show a massive revenue jump from a patent deal, but a $31M write-down reveals the risks in its diversified strategy.

Despite a revenue dip, Glacier Media's strategic exit from print has ignited a stunning return to profitability, signaling a new era for the data-driven firm.

As Aspen Aerogels prepares for a key investor conference, its leadership will detail a strategy balancing market headwinds with its critical role in EV safety.

IFF sheds its Food Ingredients unit to focus on high-margin innovation in Taste, Scent, and Health, unlocking a multi-billion dollar capital return plan.

A 22% AFFO surge and record RevPAR aren't luck. Inside Chatham Lodging's Q2 success driven by strategic buys and relentless operational efficiency.

A deep dive into Westlake's stunning Q2 turnaround, where a $600M strategic plan met global supply shocks, creating a powerful recovery amid market chaos.

As Organigram preps its Q3 results, all eyes are on its German expansion and its ability to defend its top spot in the competitive Canadian market.

MagIron unveils a multi-billion dollar plan to end U.S. reliance on imported pig iron, a critical step for national security and steel decarbonization.

As corporate buyers reshape healthcare, a new guide urges independent doctors to control their destiny by understanding their practice's true value and exit options.

A major property sale in Pärnu falls apart, leaving Nordic Fibreboard with a strategic void. We explore the risks of 'conditions precedent' and what this means for the company.

The creation of an offshore energy titan moves one step closer with US antitrust approval, but a deeper probe in Europe will decide its ultimate fate.

Abu Dhabi's healthcare giant reports a 20% profit jump, fueled by aggressive European expansion. Its strategy reveals a blueprint for a new kind of global power.

While global industrial markets waver, refractory leader RHI Magnesita proves strategic self-help can deliver powerful growth. Here's how they're doing it.

Amid production stoppages from extreme weather, nuclear operator Orano reveals a complex financial picture and a bold strategy for US expansion and diversification.

PHINIA posts strong Q2 sales and announces a key acquisition to bolster its supply chain, signaling a dual focus on current performance and long-term resilience.

SunCoke Energy's stellar Q2 results reveal a masterstroke in strategy, with its Phoenix acquisition driving record growth and diversifying the firm's future.

Amid record revenues, Martin Marietta's blockbuster deal for Lhoist North America signals a bold pivot beyond construction into industrial minerals.

The science firm sees a return to growth, driven by its Materials unit. A strategic review of its Performance & Care segment signals a major shift.